Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $14.8300 (0.88%) ($14.4000 - $15.1300) on Wed. Aug. 7, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.98% (three month average) | RSI | 45 | Latest Price | $14.8300(0.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.7% a day on average for past five trading days. | Weekly Trend | AUTL advances 1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) DRIV(15%) IBB(14%) BOTZ(13%) EWI(13%) IWC(13%) | Factors Impacting AUTL price | AUTL will decline at least -1.99% in a week (0% probabilities). VXX(-9%) VIXM(-8%) TLT(-7%) BWX(-3%) SHY(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.99% (StdDev 3.98%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
1 - 5 Day Possible Target | $2.55(-82.81%) | Resistance Level | $14.95 | 5 Day Moving Average | $14.72(0.75%) | 10 Day Moving Average | $14.75(0.54%) | 20 Day Moving Average | $14.95(-0.8%) | To recent high | -41.4% | To recent low | 12.9% | Market Cap | $775m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |